Skip to main content

Paired Ends: Carol Cox, Louise Mawhinney

Premium

Life Technologies has appointed Carol Cox to senior vice president of external affairs and corporate communications, a newly created position. Cox has served as vice president of investor relations of Life Tech since she joined the company in December 2011. Previously, she was vice president of investor relations at CareFusion and vice president of global corporate communications and investor relations at Barr Pharmaceuticals. She holds a BA in international relations from the University of Virginia.


Louise Mawhinney, formerly chief financial officer of Helicos, has been appointed to chief financial officer of Aratana Therapeutics. She has also held positions as chief financial officer and vice president of Ikonisys and chief financial officer and founding member of eSpendwise. She holds a Master's degree from the University of St. Andrews in Scotland.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.